DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Tagami T, Kopp P, Johnson W. et al.
The thyroid hormone receptor variant α2 is a weak antagonist because it
is deficient in interactions with nuclear receptor corepressors*.
Endocrinology 1998;
139: 2535-2544
DOI: 10.1210/endo.139.5.6011.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.